Corium Innovations
CompanyUnited States
Corium Innovations develops one asset, in phase 1 (Estradiol/Levonorgestrel Transdermal Delivery System in postmenopause). Mostly small molecule acting on ESR1 and PGR; based in the United States.
- Assets
- 1
- Furthest
- Phase 1
- Trials
- 2
- Signals
- 2
Pipeline
1Estradiol/Levonorgestrel Transdermal Delivery System
Transdermal hormone replacement therapy activating estrogen and progesterone receptors
Full company profiles: pipeline, trials, funding and people.
See Pro- Evidence behind the mechanisms2
- Trials2
- Signals2
- Similar companies6
Updated 7 Oct 2026 · 3 sources